Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...

Here, doctors explain which COVID-19 vaccine is better when comparing Moderna, Pfizer, and Novovax. Plus, the efficacy of ...

Shares of Novavax Inc. NVAX inched 0.15% higher to $13.04 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.45% ...

We recently compiled a list of the 10 High-Flying Stocks to Buy Now. In this article, we are going to take a look at where ...

Novavax (NVAX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

COVID-19 is a tricky virus, it changes and evolves all the time. So, as we learn in this story, we can’t let our guard down.

Novavax's financial position improved significantly with a $570 million cash infusion from Sanofi. Find out why I remain ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Novavax (NVAX) shares climbed 15% Wednesday after Jefferies released a bullish note on the company’s prospects after meeting ...

Which COVID vaccine is better of the Pfizer, Modern and Novavax options? Here's how they compare with safety and efficacy and ...

In terms of valuation, Novavax Inc’s market capitalization stands at $2.18 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value.